A noninvasive method for monitoring kidney fibrosis and graft survival
NASH / Fibrosis
Nonalcoholic fatty liver disease (NAFLD) remains a major cause of liver-related morbidity and mortality worldwide. This complex disease is associated with obesity, diabetes, and dyslipidemia, but has been increasingly recognized in normal-weight individuals. Explore our articles, news, literature reviews, tips, and more on NASH research.
State-of-the art techniques for evaluating liver fibrosis
Potective role elucidated thanks to pERK assay kit. A new signaling path...